SARS-CoV-2 IgG seroprevalence among medical staff in a general hospital that treated patients with COVID-19 in Japan: retrospective evaluation of nosocomial infection control

J Hosp Infect. 2021 Jan:107:103-104. doi: 10.1016/j.jhin.2020.10.001. Epub 2020 Oct 9.

Authors

M Hibino¹, S Iwabuchi², H Munakata²

Affiliations

¹ Department of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, Fujisawa, Kanagawa, Japan. Electronic address: [email protected].
² Centre for Hepato-Biliary-Pancreatic and Digestive Disease, Shonan Fujisawa Tokushukai Hospital, Fujisawa, Kanagawa, Japan.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Antibodies, Viral / blood*
COVID-19 / epidemiology*
COVID-19 / immunology*
Cross Infection / immunology
Cross Infection / prevention & control*
Cross Infection / virology
Female
Hospitals, General / statistics & numerical data
Humans
Immunoglobulin G / blood*
Infection Control
Male
Middle Aged
Personnel, Hospital / statistics & numerical data*
Retrospective Studies
SARS-CoV-2 / immunology
Seroepidemiologic Studies
Young Adult

Substances

Antibodies, Viral
Immunoglobulin G